Loading...
Loading...
Holder clone rankings through .
Of the 15 tracked institutions holding AVTX, 6 have a 3-year clone track record — 5 of them beat the S&P. Average holder's clone alpha: +4.0pt. It's a gauge of who owns the name, not just how many.
Among the 15 tracked institutional investors we monitor, AVTX (AVALO THERAPEUTICS INC) is held with a combined value of $331.24M across 21,449,968 shares. The largest holder is FMR LLC with a position worth $80.49M. 3 funds opened new positions in the most recent quarter. 6 funds increased their holdings. 4 funds reduced their position.
Total Institutional Value
$331.24M
Total Shares Held
21,449,968
Institutional Holders
15
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | FMR LLC | $80.49M | 0.00% | +2.9% |
| 2 | BlackRock, Inc. | $76.03M | 0.00% | +13.6% |
| 3 | STATE STREET CORP | $39.29M | 0.00% | -11.3% |
| 4 | PRICE T ROWE ASSOCIATES INC /MD/ | $29.39M | 0.00% | +46.2% |
| 5 | Point72 Asset Management, L.P. | $24.91M | 0.04% | -31.9% |
| 6 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $24.53M | 0.03% | -7.5% |
| 7 | RA CAPITAL MANAGEMENT, L.P. | $15.33M | 0.15% | - |
| 8 | VANGUARD GROUP INC | $14.60M | 0.00% | +16.1% |
| 9 | BAKER BROS. ADVISORS LP | $8.43M | 0.04% | - |
| 10 | CITADEL ADVISORS LLC | $5.69M | 0.00% | +14.6% |
As of the latest SEC 13F filings, FMR LLC is the largest institutional holder of AVTX with a position worth $80.49M, representing 0.00% of their portfolio. In total, 15 institutional investors hold AVTX with a combined value of $331.24M.
In the most recent quarter, 3 funds opened a new position in AVTX. Additionally, 6 increased their holdings and 4 reduced their positions.
Institutional investors hold $331.24M worth of AVTX stock across 15 positions. The largest institutional holder is FMR LLC with $80.49M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For AVTX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
One weekly email with notable insider buys, sells and congressional disclosures. Unsubscribe anytime.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
| — |
| 3.0% |
| 2026-11-16 |
| — | 7.4% | 2026-11-13 |
| — | 4.8% | 2026-11-10 |
| — | 0.9% | 2026-11-06 |
| — | 9.8% | 2026-11-05 |
| — | 5.2% | 2026-10-29 |
| — | 6.3% | 2026-08-14 |
| — | — | 2026-08-14 |
| — | 5.9% | 2026-08-14 |
SEC Schedule 13D (activist) and 13G (passive) filings for AVTX. Filed when an investor acquires 5%+ ownership.
Last Close
$6.70
2026-11-18
YTD
-60.6%
0% of 52-week range